Seeking to establish the cultivation of pluripotent stem cells in 10-liter bioreactors and make it more reliable and cost-effective for industrial production: Prof. Dr. Robert Zweigerdt (left) and Dr. Kevin Cyrys.
Dr. Lika Drakhlis and Prof. Dr. Robert Zweigerdt aim to integrate 3D organoids into a multilayer electrode network to better predict the cardiac safety of medications.
Developing a novel, individually controllable implant for glaucoma: Dr. Maximilian Binter (left) and Dr. Heiko Fuchs.
Small but sufficient: Prof. Dr. Robert Zweigerdt and Prof. Dr. Ulrich Martin present the new 300-milliliter bioreactor.
MHH biochemist is researching alternatives to antibiotics and has received two million euros from the European Union.
In the MIGRATe project, Professor Dr James Thackeray, a molecular medicine specialist at the Clinic for Nuclear Medicine at the Hannover Medical School (MHH), will research non-invasive molecular imaging approaches. The aim is to examine inflammatory cells and the activation of fibroblasts in the heart and in the network organs connected to it, and thus to precisely control targeted therapeutic interventions. This should lead to better therapy after a heart attack.